LEO Pharma and non-profit organisation DEBRA Research have announced a collaboration aimed at accelerating the development of treatments for epidermolysis bullosa (EB). The non-exclusive strategic ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

X-Elio will supply 245GWh of clean energy annually to four pharmaceutical companies through its Lorca Solar project.